In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Researchers have identified a new enzyme target that may influence multiple processes linked to Alzheimer’s disease, ...

Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

Add Yahoo as a preferred source to see more of our stories on Google. A new drug could halt the progression of Alzheimer’s disease. Trials suggest the treatment, called trontinemab, could be the most ...

Discover how AI is reshaping Alzheimer’s and dementia care through early detection, faster clinical trials, and improved ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...

Dear Doctors: I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline. There are also new tests to determine if a person is in the ...

There are more than 7 million people currently living with the devastating disease known as Alzheimer's. Alzheimer's causes changes to the brain that result in memory loss, moodiness, trouble learning ...

Drugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer’s disease in mice, a study led by the Cyprus Institute of Neurology and Genetics (CING) shows, but the ...

FILE PHOTO: A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering from Alzheimer's disease at the Memory Centre at the Department of ...